Analystreport

BioXcel Therapeutics Inc (NASDAQ: BTAI) is now covered by analysts at Barclays. They set an "overweight" rating on the stock.

BioXcel Therapeutics, Inc.  (BTAI) 
Last bioxcel therapeutics, inc. earnings: 11/14 07:00 am Check Earnings Report